PRODUCTS

INTERNATIONAL  /  PASIREOTIDE «  BACK TO "INTERNATIONAL"

Included in Global & USA Product Guide
Under development Long-acting Injectable (LAI)
Product Pharmaceutical form Strengths Therapeutic category
  • Pasireotide
  • Long-acting Injectable
  • 20mg/vial
  • 40mg/vial
  • 60mg/vial
  • Treatment of patients with acromegaly who have had an inadequate response to surgery and/or for whom surgery is not an option

Other products in "International"